IGF-I treatment of patients with Laron syndrome

Laron Syndrome - From Man to Mouse: Lessons from Clinical and Experimental Experience

Volumn , Issue , 2011, Pages 343-380

  Laron, Zvi ^a  

^a SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84873674517     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-642-11183-9_42     Document Type: Chapter

References (58)

1. Arad I, Laron Z (1979) Standards for upper/lower body segment/ sitting height-subischial leg length, from birth to 18 years in girls and boys. In: Proceedings of the 1st international congress of auxology, Rome, 1977. Centro Auxologia Italiano di Piancavallo, Milan, pp 159-164
2. Azcona C, Preece MA, Rose SJ, Fraser N, Rappaport R, Ranke MB, Savage MO (1999) Growth response to rhIGF-I 80 mg/kg twice daily in children with growth hormone insensitivity syndrome: Relationship to severity of clinical phenotype. Clin Endocrinol (Oxf) 51:787-792
3. Backeljauw PF, Underwood LE (1996) Prolonged treatment with recombinant insulin-Like growth factor-1 in children with growth hormone insensitivity syndrome-A clinical research center study. J Clin Endocrinol Metab 81:3312-3317
4. Backeljauw PF, Underwood LE, The GHIS Collaborative Group (2001) Therapy for 6.5-7.5 years with recombinant insulinlike growth factor I in children with growth hormone insensitivity syndrome: A clinical research center study. J Clin Endocrinol Metab 86:1504-1510
5. Besson A, Salemi S, Eble AF, Joncourt FS, Gallati S, Jorge AA, Mullis PE (2004) Primary GH insensitivity (Laron syndrome) caused by a novel 4 kb deletion encompassing exon 5 of the GH receptor gene: Effect of intermittent long-Term treatment with recombinant human IGF-I. Eur J Endocrinol 150:635-642
6. Blundell TL, Humbel RE (1980) Hormone families: Pancreatic hormones and homologous growth factors. Nature 287:781-787
7. Chernausek SD, Backeljauw PF, Frane J, Kuntze J, Underwood LE, GH Insensitivity Syndrome Collaborative Group (2007) Long-Term treatment with recombinant insulin-Like growth factor (IGF)-I in children with severe IGF-I deficiency due to growth hormone insensitivity. J Clin Endocrinol Metab 92:902-910
8. Dahms WT, Owens RP, Kalhan SC, Kerr DS, Danish RK (1989) Urea synthesis, nitrogen balance and glucose turnover in growth hormone deficient children before and after growth hormone administration. Metabolism 38:197-203
9. Eshet R, Klinger B, Silbergeld A, Laron Z (1993) Modulation of insulin like growth factor I (IGF-I) binding sites on erythrocytes by IGF-I treatment in patients with Laron syndrome (LS). Regul Pept 48:233-239
10. Frane J, Bailly J, Chernausek SD, Kuntze J (2006) Growth responses to higher dose recombinant human IGF-I (rhIGF-I) in children with severe primary IGF-I deficiency (IGFD) due to growth hormone insensitivity (GHIS) (abstract P03-619). Horm Res 65(SUPPL4):180
11. Gibaldi M, Perrier D (1975) Pharmacokinetics. Marcel Dekker, New York, pp 3-6
12. Gil-Ad I, Koch Y, Silbergeld A, Dickerman Z, Kaplan B, Weizman A, Laron Z (1996) Differential effect of insulinlike growth factor I (IGF-I) and growth hormone (GH) on hypothalamic regulation of GH secretion in the rat. J Endocrinol Invest 19:542-547
13. Greulich WW, Pyle SI (1959) Radiographic atlas of skeletal development of the hand and wrist, 2nd edn. Stanford University Press, Stanford, CA
14. Guevara-Aguirre J, Rosenbloom AL, Vasconez O, Martinez V, Gargosky SE, Allen L, Rosenfeld RG (1997) Two year treatment of growth hormone (GH) receptor deficiency with recombinant insulin-Like growth factor I in 22 children: Comparison of two dosage levels and to GH-Treated GH deficiency. J Clin Endocrinol Metab 82:629-633
15. Guler HP, Zapf J, Froesch ER (1987) Short term metabolic effect of recombinant human insulin like growth factor in healthy adults. N Engl J Med 317:137-140
16. Guler HP, Zapf J, Schmid C, Froesch ER (1989) Insulin growth factor I and II in healthy man. Estimations of half lives and production rates. Acta Endocrinol 121:753-758
17. Harbison MD, Gertner JM (1990) Permissive action of growth hormone on the renal response to dietary phosphorus deprivation. J Endocrinol Metab 70:1035-1040
18. Heding L (1972) Determination of a total serum insulin (IRI) in treated diabetic patients. Diabetologia 8:260-266
19. Heinrichs C, Vis HL, Bergmann P, Wilton P, Bourguignon JP (1993) Effects of 17 months treatment using recombinant insulin-Like growth factor-1 in two children with growth hormone insensitivity (Laron) syndrome. Clin Endocrinol (Oxf) 38:647-651
20. Jones JI, Clemmons DR (1995) Insulin-Like growth factors and their binding proteins: Biological actions. Endocr Rev 16:3-34
21. Kaji H, Nose O, Tajiri H (1997) Novel compound heterozygous mutation of growth hormone (GH) receptor gene in a patient with GH insensitivity syndrome. J Clin Endocrinol Metab 82:3705-3709
22. Kanety H, Silbergeld A, Klinger B, Karasik A, Baxter RC, Laron Z (1997) Longterm effects of insulin-Like growth factor-I (IGF-I) on serum IGF-I, IGF-binding protein-3 (IGFBP3) and acid labile subunit in Laron syndrome patients with normal GHBP. Eur J Endocrinol 137:626-630
23. Klinger B, Laron Z (1995) Three year IGF-I treatment of children with Laron syndrome. J Pediatr Endocrinol Metab 8:149-158
24. Klinger B, Garty M, Laron Z (1990) Elimination characteristics of intravenously administered rIGF-I in Laron type dwarfs (LTD). Dev Pharmacol Ther 15:196-199
25. Krzisnik C, Battelino T (1997) Five year treatment with IGF-I of a patient with Laron syndrome in Slovenia (a follow-up report). J Pediatr Endocrinol Metab 10:443-447
26. Laron Z (1993) One-year treatment with IGF-I of children with Laron syndrome. Clin Courier 11:7-8
27. Laron Z (2008) Insulin-Like growth factor-I treatment of children with Laron syndrome (primary growth hormone insensitivity). Pediatr Endocrinol Rev 5:766-771
28. Laron Z, Mannheimer S (1966) Measurement of human growth hormone. Description of the method and its clinical application. Isr J Med Sci 2:115-119
29. Laron Z, Pertzelan A, Doron M, Assa S, Keret R (1977) The effect of dihydrosomatostatin in dwarfism with high plasma immunoreactive growth hormone. Horm Metab Res 9:338-339
30. Laron Z, Roitman A, Kauli R (1979) Effect of hGH therapy on the head circumference in children with hypopituitarism. Clin Endocrinol 10:393-399
31. Laron Z, Klinger B, Erster B, Anin S (1988) Effect of acute administration of insulin like growth factor in patients with Laron type dwarfism. Lancet 2:1170-1172
32. Laron Z, Klinger B, Silbergeld A, Lewin B, Erster B, Gil-Ad I (1990) Intravenous administration of recombinant IGF-I lowers serum GHRH and TSH. Acta Endocrinol 123:378-382
33. Laron Z, Klinger B, Jensen LT, Erster B (1991) Biochemical and hormonal changes induced by one week of administration of rIGF-I to patients with Laron type dwarfism. Clin Endocrinol 35:145-150
34. Laron Z, Anin S, Klipper Aurbach Y, Klinger B (1992a) Effects of insulin like growth factor on linear growth, head circumference and body fat in patients with Laron type dwarfism. Lancet 339:1258-1261
35. Laron Z, Suikkari AM, Klinger B, Silbergeld A, Pertzelan A, Seppala M, Koivisto VA (1992b) Growth hormone and insulin-Like growth factor regulate insulin-Like growth factor binding protein in Laron type dwarfism, growth hormone deficiency and constitutional growth retardation. Acta Endocrinol 127:351-358
36. Laron Z, Lilos P, Klinger B (1993) Growth curves for Laron syndrome. Arch Dis Child 68:768-770
37. Laron Z, Klinger B, Silbergeld A (1999) Serum insulin like growth factor I (IGF-I) levels during long term IGF-I treatment in children and adults with primary GH resistance (Laron syndrome). J Pediatr Endocrinol Metab 12:145-152
38. LeRoith D, Werner H, Beitner-Johnson D, Roberts CT Jr (1996) Molecular biology of IGF-I receptor. In: Merimee T, Laron Z (eds) Growth hormone, IGF-I and growth: New views of old concepts. Modern endocrinology and diabetes, vol 4. Freund Publishing House Ltd., London-Tel Aviv, pp 73-99
39. Merimee T, Laron Z (1996) Growth hormone, IGF-I and growth: New views of old concepts. In: Modern endocrinology and diabetes, vol 4. Freund Publishing House Ltd., London-Tel Aviv, pp 165-197
40. Nellhaus G (1967) Head circumference from birth to 18 years. Pediatrics 41:106-114
41. Niwa M, Sato Y, Saito Y, Uchiyama F, Ono H, Yamashita M, Kitaguchi T, Shiga Y, Notani J, Yamada H, Ishii Y, Ueda I, Takagi Y (1986) Chemical synthesis, cloning and expression of genes for human somatomedin C (insulin like growth factor I) and 59Val somatomedin C. Ann N Y Acad Sci 469:31-52
42. Ranke MB, Savage MO, Chatelain PG, Preece MA, Rosenfeld RG, Blum WF, Wilton P (1995) Insulin-Like growth factor I improves height in growth hormone insensitivity: Two years' results. Horm Res 44:253-264
43. Ranke MB, Savage MO, Chatelain PG, Preece MA, Rosenfeld RG, Wilton P, Working Group on Growth Hormone Insensitivity Syndromes (1999) Long-Term treatment of growth hormone insensitivity syndrome with IGF-I. Results of the European Multicentre Study. The Working Group on Growth Hormone Insensitivity Syndromes. Horm Res 51:128-134
44. Rinderknecht E, Humbel RE (1978) The amino acid sequence of human insulin like growth factor I and its structural homology, with proinsulin. J Biol Chem 253:2769-2776
45. Savage M, Underwood L, Yordam N, Yuksel B, Smith A, Attie K, Camacho Hubner C (2006) Treatment of short stature in children with severe primary IGF-I deficiency with once daily rhIGF-I/rhIGFBP-3 administration [abstract CF1-100]. Horm Res 65(SUPPL4):30
46. Scharf J, Ramadori G, Braulke T, Hartmann H (1996) Synthesis of insulinlike growth factor binding proteins and of the acid-Labile subunit in primary cultures of rat hepatocytes, of Kupffer cells, and in cocultures: Regulation by insulin, insulinlike growth factor, and growth hormone. Hepatology 23:818-827
47. Silbergeld A, Jaber L, Lilos P, Laron Z (1988) A comparison of IGF-I levels measured by two commercially available radioimmunoassay. Acta Endocrinol 119:333-338
48. Silbergeld A, Lilos P, Laron Z (2007) Foot length before and during insulin-Like growth factor-I treatment of children with Laron syndrome compared to human growth hormone treatment of children with isolated growth hormone deficiency. J Pediatr Endocrinol Metab 20:1325-1328
49. Tanner JM, Whitehouse RH, Takaishi M (1966) Standards from birth to maturity for height, weight, height velocity and weight velocity in British children. Arch Dis Child 41:613-635
50. Uchijima Y, Takenaka A, Takahashi S, Noguchi T (1995) Production of insulin-Like growth factors and their binding proteins in primary cultures of rat liver parenchymal and nonparenchymal cells. Biosci Biotechnol Biochem 59: 1503-1515
51. Underwood L, Chernausek SD, Kuntze J, Frane J, Bright GM (2004) Efficacy of long-Term treatment with recombinant human IGF-I (rhIGF-I) of children with GH insensitivity. In: 86th annual meeting of the Endocrine Society, New Orleans, LA [abstract P3-451], p 575
52. Walker JL, Ginalska Malinoska M, Romer TE, Pucilowska JB, Underwood LE (1991) Effects of the infusion of insulin like growth factor I in a child with growth hormone insensitivity syndrome (Laron dwarfism). N Engl J Med 324:1483-1488
53. Walker JL, Crock PA, Behncken SN, Rowlinson SW, Nicholson LM, Boulton TJC, Waters MJ (1998) A novel mutation affecting the interdomain link region of the growth hormone receptor in a Vietnamese girl, and response to long-Term treatment with recombinant human insulin-Like growth factor-1 and luteinizing hormone-releasing hormone analogue. J Clin Endocrinol Metab 83:2554-2561
54. Werner H, Weinstein D, Bentov I (2008) Similarities and differences between insulin and IGF-I: Structures, receptors, and signaling pathways. Arch Physiol Biochem 114:17-22
55. Zapf J, Hauri C, Waldvogel M, Froesch ER (1986) Acute and metabolic effects and half-Lives of intravenous administered insulin like growth factors I and II in normal and hypophysectomized rats. J Clin Invest 77:1768-1775
56. Zapf J, Hauri M, Waldvogel M, Futo E, Hasler H, Binz K, Guler HP, Schmid C, Froesch ER (1989) Recombinant human insulinlike growth factor I induces its own specific carrier protein in hypophysectomized and diabetic rats. Proc Natl Acad Sci U S A 86:3813-3817
57. Zapf J, Gosteli-Peter M, Schmid C (1996) Insulin-Like growth factor binding proteins (IGFBPs). In: Merimee T, Laron Z (eds) Growth hormone, IGF-I and growth: New views of old concepts. Modern endocrinology and diabetes, vol 4. Freund Publishing House Ltd., London-Tel Aviv, pp 45-71
58. Zucchini S, Scarano E, Baldazzi L, Mazzanti L, Pirazzoli P, Cacciari E (2005) Final height in a patient with Laron syndrome after long-Term therapy with rhlGF-I and shortterm therapy with LHRH-Analogue and oxandrolone during puberty. J Endocrinol Invest 28:274-279